Načítá se...
TNFerade, an innovative cancer immunotherapeutic
Tumor necrosis factor-α (TNF-α) is a chemokine with effective tumoricidal properties. However, severe systemic toxicity limits its use of as anticancer agent. TNFerade is a novel replication deficient adenovector based gene therapy, which enables the radiation inducible translation of human TNF-α ge...
Uloženo v:
| Vydáno v: | Indian J Pharmacol |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Medknow Publications & Media Pvt Ltd
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4621666/ https://ncbi.nlm.nih.gov/pubmed/26600634 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0253-7613.165190 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|